Form 4 Tracker
Janet MJ Hammond

Chief Development Officer · 1 filing · Latest: Jan 31, 2026

Atea Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AVIR
Janet MJ HammondChief Development OfficerJan 31, 2026
Option Exercise
58,050141,801